Agreement signedPublished 22 Sep 2022

Sagard Healthcare Partners (Delaware) LP /
Albireo Pharma, Inc. and Albireo AB

Sagard Healthcare Partners (Delaware) LP agrees to buy Albireo Pharma, Inc. and Albireo AB

Price
$115m
Stage
Agreement signed
Source · 22 Sep 2022
01 / BuyerSagard Healthcare Partners (Delaware) LP
02 / TargetAlbireo Pharma, Inc. and Albireo AB
01

What happened

Sagard Healthcare Partners (Delaware) LP agreed to acquire Albireo Pharma, Inc. and Albireo AB for $115 million, according to a filing dated Sept. 22, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Sagard Healthcare Partners (Delaware) LP agrees to buy Albireo Pharma, Inc. and Albireo AB

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.